Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Rotigotine

A non-ergoline dopamine agonist that stimulates dopamine receptors in the brain, given as a patch: approved in Europe in 2006 for Parkinson's disease, since 2008 it has also been used for restless legs syndrome. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?In 2007 it became the first Parkinson's treatment in patch form approved in the United States: through the skin, the drug is released steadily over 24 hours.

RotigotineGo to the active ingredient →
RotigotineActive ingredientRotigotineCat. No. P-R089-001CAS 99755-59-6

EDQM standards 7

The official European Pharmacopoeia standards for this family.

Reference substanceRotigotine CRSEDQM code Y0002010Family Rotigotine

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.